Treatment of acute ischemic stroke in China

Chinese Journal of Neurology

Volumn 42, Issue 4, 2009, Pages 223-228

  Zhang, Jing Fen ^a   Huang, Yi Ning ^b  

^a BAOTOU CENTRAL HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Brain ischemia; China; Drug therapy; Stroke

Indexed keywords

EID: 84861180412     PISSN: 10067876     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1006-7876.2009.01.003     Document Type: Article

References (36)

1. Adams HP Jr, Adams BJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke, 2003, 34: 1056-1083.
2. 2002, 35: 210-213.
3. 2005, 38: 17-21.
4. Brown DL, Lisabeth LD, Garcia NM, et al. Emergency department evaluation of ischemic stroke and TTA: the BASIC project. Neurology, 2004, 63: 2250-2254.
5. Deng YZ, Reeves MJ, Jacobs BS, et al. IV tissue plasminogen activator use in acute stroke: experience from a statewide registry. Neurology, 2006, 66: 306-312.
6. Nadeau JO, Shi S, Fang J, et al. TPA use for stroke in the registry of the Canadian stroke network. Can J Neurol Sci, 2005, 32: 433-439.
7. Morgenstem LB, Staub L, Chan W, et al. Improving delivery of acute stroke therapy: the TLL Temple Foundation stroke project. Stroke, 2002, 33: 160-166.
8. Grotta JC, Burgin WS, El-Mitwalli A, et al. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol, 2001, 58: 2009-2013.
9. Szoeke C E, Parsons MW, Butcher KS, et al. Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital. Med J Aust, 2003, 178: 324-328.
10. Katzan IL, Furlan AJ, Lloyd LE, et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA, 2000, 283: 1151-1158.
11. Morgenstem LB, Bartholomew LK, Grotta JC, et al. Sustained benefit of a community and professional intervention to increase acute stroke therapy. Arch Intern Med, 2003, 163: 2198-2202.
12. Wein TH, Staub L, Felberg R, et al. Activation of emergency medical services for acute stroke in a nonurban population: the T. L. L. Temple Foundation Stroke Project. Stroke, 2000, 31: 1925-1928.
13. Morgenstem LB, Gonzales NR, Maddox KE, et al. A randomized, controlled trial to teach middle school children to recognize stroke and call 911. The kids identifying and defeating stroke project. Stroke, 2007, 38: 2972-2978.
14. Kleindorfer D, Kissela B, Schneider A, et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke, 2004, 35: e27-29.
15. Hickenbottom SL, Morgenstem LB. Educating North America: lessons learned. J Stroke Cerebrovasc Dis, 2002, 11: 174-182.
16. Barson W, Brott T, Olinger C, et al. Identification and entry of the patient with acute cerebral infarction. Ann Emerg Med, 1988, 17: 1192-1195.
17. Silvestrelli G, Parnetti L, Paciaroni M, et al. Early admission to stroke unit influences clinical outcome. Eur J Neurol, 2006, 13: 250-255.
18. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19, 435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet, 1997, 349: 1569-1581.
19. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20, 000 patients with acute ischaemic stroke. Lancet, 1997, 349: 1641-1649.
20. Chen ZM, Sandercock P, Pan HC, et al. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke, 2000, 31: 1240-1249.
21. Hillen T, Dundas R, Lawrence E, et al. Antithrombotic and antihypertensive management 3 months after ischemic stroke: a prospective study in an inner city population. Stroke, 2000, 31: 469-475.
22. Touzé E, Mas JL, Röther J, et al. Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) registry. Stroke, 2006, 37: 2880-2885.
23. Wardlaw JM, del Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, 3: CD000213.
24. Sacco RL, Chong JY, Prabhakaran S. Experimental treatments for acute ischaemic stroke. Lancet, 2007, 369: 331-341.
25. Davalos A, Castillo J, Alvarez-Sabm J, et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke, 2002, 33: 2850-2857.
26. Albers GW, Goldstein LB, Hall D, et al. Aptiganel Acute Stroke Investigators. Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. JAMA, 2001, 286: 2673-2682.
27. Lees KR, Zivin JA, Ashwood T, et al. NXY-059 for acute ischemic stroke. N Engl J Med, 2006, 354: 588-600.
28. Ly JV, Zavala JA, Donnan GA. Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke. Expert Opin Pharmacother, 2006, 7: 1571-1581.
29. Hankey GJ. Neuroprotection for acute ischaemic stroke: hope reignited. Lancet Neurol, 2006, 5: 287-288.
30. Ginsberg MD, Palesch YY, Hill MD. The ALIAS (Albumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and progress report. Biochem Soc Trans, 2006, 34 Pt 6: 1323-1326.
31. Wang CX, Shuaib A. Neuroprotective effects of free radical scavengers in stroke. Drugs Aging, 2007, 24: 537-546.
32. Liu QY, Song J, Chen KJ. Research progress on Chinese herbal medicine for ischemic stroke. Chin J Integrated Traditional Western Med, 2000, 20: 309-312.
33. Wu B, Liu M, Liu H, et al. Meta-analysis of traditional Chinese patent medicine for ischemic stroke. Stroke, 2007, 38: 1973-1979.
34. Wang NL, Liou YL, Lin MT, et al. Chinese herbal medicine, Shengmai San, is effective for improving circulatory shock and oxidative damage in the brain during heatstroke. J Pharmacol Sci, 2005, 97: 253-265.
35. Lee IY, Lee CC, Chang CK, et al. Sheng mai san, a Chinese herbal medicine, protects against renal ischaemic injury during heat stroke in the rat. Clin Exp Pharmacol Physiol, 2005, 32: 742-748.
36. Feigin VL. Herbal medicine in stroke: does it have a future? Stroke, 2007, 38: 1734-1736.